These press releases are intended for business journalists and analysts/investors
GSK is leading the pharmaceutical sector by being first in Australia to introduce a new framework for its medical education program and interactions with healthcare professionals to increase transparency.
Read more - GSK first in Australia with new business model for the pharmaceutical industry Read more
- Assistant Minister for Science Karen Andrews opens new vaccine facility in Boronia, Victoria
- GSK awarded $1 million Federal Government grant for advanced manufacturing project
- Three-year pilot to test commercialisation
Amgen and GSK to Work Together to Ensure a Smooth Transition for
Prolia® Patients and Their Physicians
Read more - Amgen reacquires all rights to Prolia® (denosumab) in Australia Read more
Australian researchers awarded $80,000 for breakthrough in immunity
Millions more children from the world’s poorest countries are being vaccinated against more diseases than ever before.
GSK Australia is proud to be partnering with the Australian Government to provide a quadrivalent (four-strain) influenza vaccine for the National Immunisation Program (NIP) for the 2016 season.
Dr Ginni Mansberg ambassador for ‘Tried-It-All’ hay fever campaign launched today
Read more - GSK and Sun Pharma complete Opiates transaction Read more
Read more - GSK's parting gifts to local community Read more
Recall of five batches of Bactroban Cream and three batches of Bactroban Nasal Ointment